Antisense Oligonucleotides: Technological Advances, Clinical Progress, and Expanding Therapeutic Frontiers

Antisense oligonucleotides (ASOs) are emerging therapeutic agents that modulate gene expression at the RNA level, offering distinct therapeutic advantages over conventional small-molecule drugs and biologics. By directly targeting RNA, ASOs expand the spectrum of druggable targets to include those p...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Liping Xu, Huaqun Zhang, Bingchen Jiang, Yuanying Jiang, Hui Lu
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2026-04-01
Cyfres:	Pharmaceutics
Pynciau:	antisense oligonucleotides RNA-targeted therapeutics chemical modification precision medicine
Mynediad Ar-lein:	https://www.mdpi.com/1999-4923/18/4/446
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!